Harpoon Therapeutics, Inc. (HARP) Financials
HARP Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 47.6 million | 43.0 million |
| 2023-06-30 | 63.2 million | 60.2 million |
| 2023-03-31 | 80.8 million | 80.1 million |
| 2022-12-31 | 73.7 million | 68.3 million |
HARP Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -16.6 million | 918000 |
| 2023-06-30 | -15.2 million | 1.1 million |
| 2023-03-31 | -19.3 million | 1.1 million |
| 2022-12-31 | -18.4 million | 1.5 million |
HARP Net Income
No data available :(
HARP Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 31.6 million | - | 14.5 million |
| 2023-06-30 | 45.6 million | - | 15.2 million |
| 2023-03-31 | 61.4 million | - | 15.6 million |
| 2022-12-31 | 53.1 million | - | 16.0 million |
HARP Shares Outstanding
HARP Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 91000 | 12.3 million | 4.3 million | - |
| 2023-06-30 | - | 12.2 million | 3.8 million | - |
| 2023-03-31 | - | 15.2 million | 4.2 million | - |
| 2022-12-31 | 28000 | 18.9 million | 3.9 million | - |
HARP Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 4.4 million | 236000 |
| 2023-06-30 | 20.2 million | 568000 |
| 2023-03-31 | 8.6 million | 1.1 million |
| 2022-12-31 | 4.1 million | 910000 |
HARP
Price: $23.01
52 week price:
Earnings Per Share: -1.53 USD
P/E Ratio: -14.67
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 146491
Market Capitalization: 492.3 million